Patents by Inventor Stephanie Sanos

Stephanie Sanos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellin
    Patent number: 10512684
    Abstract: Provided herein are immunogenic compositions comprising a recombinant modified vaccinia virus Ankara (MVA) comprising a nucleic acid sequence encoding a flagellin, and a nucleic acid sequence encoding a heterologous disease-associated antigen, wherein the immunogenic composition induces increased T-cell and antibody mediated immune responses specific for the heterologous disease-associated antigen when administered to a subject, e.g. a human subject, and related methods and uses.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: December 24, 2019
    Assignee: Bavarian Nordic A/S
    Inventors: Henning Lauterbach, Hubertus Hochrein, Stephanie Sanos
  • METHODS AND COMPOSITIONS FOR INTRA-NASAL IMMUNIZATION WITH RECOMBINANT MVA ENCODING FLAGELLIN
    Publication number: 20170290909
    Abstract: Provided herein are immunogenic compositions comprising a recombinant modified vaccinia virus Ankara (MVA) comprising a nucleic acid sequence encoding a flagellin, and a nucleic acid sequence encoding a heterologous disease-associated antigen, wherein the immunogenic composition induces increased T-cell and antibody mediated immune responses specific for the heterologous disease-associated antigen when administered to a subject, e.g. a human subject, and related methods and uses.
    Type: Application
    Filed: September 25, 2015
    Publication date: October 12, 2017
    Applicant: Bavarian Nordic A/S
    Inventors: Henning Lauterbach, Hubertus Hochrein, Stephanie Sanos